Skip to main content

After a Rally, Biotech ETF Faces Resistance

In frustrating news for some short sellers, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) is up 7.5% in the past month and nearly 15% from its April trough. Now the largest biotech ETF by assets is facing its first legitimate tussle with a key resistance level following its bounce from its...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.